PTPN11 and cancer: We also evaluated the expression of SHP2, which dephosphorylates pSTAT1 and plays an important role in HLA-associated immune escape in other types of cancers (26), and found that regorafenib had no inhibitory effects on SHP2 gene and protein expression (Supplementary Figures 2A, B).